大流行期间显微外科自体乳房再造:单中心COVID-19经验
该单中心回顾性研究比较了2019年6月3日至12月31日(COVID前)与2020年6月3日至12月31日(COVID后)两个完全相同时间段的显微外科自体乳房再造情况。COVID后DIEP皮瓣例数减少(45例对29例),皮瓣重量显著增加,术后住院时间显著缩短,再手术率及感染、血肿、血清肿、伤口裂开等并发症率无显著差异,未记录静脉血栓栓塞或皮瓣失败病例,受训人员数量及学员与带教比例无显著差异。
要点
- COVID后DIEP皮瓣例数较前一年同期减少(45例对29例)。
- 皮瓣重量显著增加,乳房切除重量、缺血时间无显著差异。
- 术后住院时间显著缩短,再手术及主要并发症率无显著差异。
核心结论
- 尽管手术例数减少,自体乳房再造在COVID-19第一波疫情期间仍安全开展,且未影响培训。
研究设计与样本
- 单中心回顾性分析前瞻性收集的数据,比较COVID前(2019年6月3日至12月31日)与COVID后(2020年6月3日至12月31日)两个完全相同时间段。
主要发现
- COVID后DIEP皮瓣例数减少(45例对29例)。
- 乳房切除重量无显著差异,但皮瓣重量显著增加。
- 缺血时间无显著差异,术后住院时间显著缩短。
- 再手术率及非计划入院、感染、血肿、血清肿、伤口裂开率均无显著差异。
- 未记录静脉血栓栓塞或皮瓣失败病例;手术室内带教人员与学员平均数量及学员与带教比例在两组间无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: COVID-19 has disrupted the provision of breast reconstructive services throughout the UK. Autologous free flap breast reconstruction was restarted in our unit on 3 June 2020. We aimed to compare the unit's performance of microsurgical autologous breast reconstruction in the "post-COVID" period compared with the exact time period in the preceding year. METHODS: We retrospectively reviewed prospectively collected data in the "pre-COVID" (from 3 June 2019 to 31 December 2019) and "post-COVID" period (from 3 June 2020 to 31 December 2020). Patient demographics included age, body mass index, co-morbidities, Anaesthesiologists (ASA) grade and smoking status. Surgical factors included neoadjuvant chemotherapy, previous chest wall radiotherapy, unilateral or bilateral reconstruction, reconstruction timing, number of pedicles, contralateral symmetrisation and other procedures. dependant variables were ischaemic time, operative time, mastectomy weight, flap weight, length of stay, return to theatre and complication rates. The number of trainers and trainees present in theatre was recorded and analysed. RESULTS: Fewer DIEP flaps were performed in the "post-COVID" period (45 vs. 29). No significant difference was observed in mastectomy resection weight, but flap weight was significantly increased. No significant difference was found in ischaemic time as well. The postoperative length of stay was significantly reduced. No significant difference was found in rates of return to theatre, unplanned admission, infection, haematoma, seroma or wound dehiscence. No cases of venous thromboembolism or flap failures were recorded. The mean number of trainers and trainees, and the trainee-to-trainer ratio was not found to be significantly different between cohorts. CONCLUSION: Although fewer cases were performed, autologous breast reconstruction was safely delivered throughout the COVID-19 pandemic in the first wave without affecting training.
引用
- Ho W, Köhler G, Haywood RM, et al. Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience. J Plast Reconstr Aesthet Surg. 2021. PMID: 34756656. doi:10.1016/j.bjps.2021.09.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。